The advanced lung cancer inflammation index (ALI) is determined by serum albumin (ALB), body mass index (BMI), and NLR, which constitute a composite index, and multiple studies have shown that ALI has good predictive value in assessing the survival prognosis of cancer patients [9–11]. The gene discussed is ALB; the disease is lung carcinoma.